Editorial Volume 9, Issue 5 pp 1357—1358

Repurposing ARBs as treatments for breast cancer

Amee J. George 1, 2, 3, , Andrew Allen 4, , Ashwini L. Chand 5, 6, ,

  • 1 The ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
  • 2 Department of Pathology, University of Melbourne, VIC, Australia
  • 3 School of Biomedical Sciences, University of Queensland, QLD, Australia
  • 4 Department of Physiology, University of Melbourne, VIC, Australia
  • 5 Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia
  • 6 School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia

received: May 25, 2017 ; published: May 31, 2017 ;

How to Cite

Copyright: George et al. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.